Daten des Robert Koch-Instituts: 7-Tage-Inzidenz & Hospitalisierungen & GrippeWeb-Wochenbericht & AMELAG
Das aktuelle Corona-Krankheitsaufkommen in Deutschland beträgt schätzungsweise 21 Fälle pro 100.000 Einwohner, was bedeutet, dass ca. eine von 3.333 Personen derzeit akut infiziert ist (angenommen sind Ø 10 Tage Infektionsdauer). Das Robert-Koch-Institut (RKI) meldet eine auf meldepflichtigen PCR-Tests basierte Inzidenz von 0, wobei auf jede offiziell registrierte Infektion etwa 206 weitere unentdeckte Fälle entfallen. Informationen zur aktuellen Verteilung zirkulierender SARS-CoV-2-Varianten finden sich im RKI-Dashboard.
Die auf dem GrippeWeb-Wochenbericht basierte Inzidenz aller Atemwegserkrankungen beträgt 5.603 pro 100.000 Einwohner, was bedeutet, dass ca. eine von 18 Personen derzeit akut infiziert ist (angenommen sind Ø 7 Tage Infektionsdauer; Vergleich zu den Vorjahren). Stand: 20.05.2026
Der Risikorechner macht infektiöse Aerosol-Gefahren in Innenräumen sichtbar und unterstützt dabei, das tatsächliche Ansteckungsrisiko realistisch einzuschätzen.
Risiko berechnen
Rund um das Immunsystem gibt es viele Mythen und Missverständnisse. Dieser Text klärt einige häufige Fragen wissenschaftlich fundiert auf.
Weiterlesen
Nirmatrelvir-ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022-23:virological and immunological results of an open-label randomised trial (PANORAMIC). 23.03.2027
Validation of an MLV-based SARS-CoV-2 pseudovirus neutralization assay substantiates L455S-mediated antibody escape. 20.05.2026
Deep learning–assisted, pathogenesis-informed lung histopathology scoring in preclinical mouse models of SARS-CoV-2 and influenza A infection 20.05.2026
Comparative Performance Analysis of Commercial SARS-CoV-2 RNA Detection Assays:Implications for Sensitivity, Specificity, Accuracy, and Diagnostic Response Time 20.05.2026
Coronavirus diversity and SARS-CoV-2 exposure at the wildlife–human interface in Northern Italy 20.05.2026
BIOLOGICAL AND MOLECULAR GENETIC FEATURES OF SARS-COV-2 20.05.2026
Absolute Binding Free Energy Calculations between the SARS-CoV2 Main Protease and 130 Drug Leads Using Implicit Ligand Theory 20.05.2026
Absolute Binding Free Energy Calculations between the SARS-CoV-2 Main Protease and 130 Drug Leads Using Implicit Ligand Theory 20.05.2026
Explainable convolutional neural network model provides an alternative genome-wide association perspective on mutations in SARS-CoV-2 20.05.2026
Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer 20.05.2026
X-Domain of nsp-3 Protein of the SARS-CoV-2 Coronavirus Is Capable of Deforming Membranes and Initiating of the Double-Membrane Vesicle Formation Depending on the Cholesterol Content 20.05.2026
Validation of a Mucosal IgA Assay for SARS-CoV-2 20.05.2026
Detection of SARS-CoV-2 among travellers entering Ghana through the Kotoka International Airport at the peak of the COVID-19 pandemic:2021 to 2022 20.05.2026
Prophylactic Use of Vitamin D to Maintain a Robust Immune System Against Infections Like SARS-CoV-2 20.05.2026
Effect of Percutaneous Auricular Nerve Stimulation on Fatigue in Adults with Post-COVID Fatigue (PAuSing-pCF):Results of a Randomised, Sham-Controlled Trial 20.05.2026
SARS-CoV-2 seroprevalence among pregnant women during the first three waves of the COVID-19 pandemic in southern Mozambique 20.05.2026
Marine-Derived Inhibitors Targeting the SARS-CoV-2 Spike Protein:Molecular Docking Evaluation of Manoalide, Heteronemin, and Related Compounds 20.05.2026
Social and structural determinants of SARS-CoV-2 testing and positivity among immigrant and non-immigrant children in the Lisbon Metropolitan Area, Portugal 20.05.2026
From neurotoxicity to neuroprotection:photobiomodulation against the effects of the SARS-CoV-2 spike protein in a 2D neurodegenerative model using differentiated SH-SY5Y cells 20.05.2026
CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine 20.05.2026
Variant emergence, not vaccine deployment, drives episodic positive selection on the SARS-CoV-2 spike at provincial scale in Canada 20.05.2026
SARS-CoV-2 Reinfection and Risk of Multisystem Inflammatory Syndrome in Children:A Case–Control Study 20.05.2026
Validation of an MLV-based SARS-CoV-2 pseudovirus neutralization assay substantiates L455S-mediated antibody escape 20.05.2026
SARS-CoV-2 Vaccination Status and MIS-C Incidence:A Systematic Review 20.05.2026
SARS-CoV-2 Surveillance in Free-Ranging Wildlife in the Northeastern United States, 2022–2025 20.05.2026
The SARS-CoV-2 Integrated Genomic Epidemiology Database (IGED):Linking viral genomes with patient-level metadata to advance statewide genomic surveillance in California 20.05.2026
Cell-Type Specific Effects of SARS-CoV-2 P252L Mutation on Nirmatrelvir Sensitivity 20.05.2026
Changes in the Association Between Wastewater SARS-CoV-2 and Clinical Indicators Following the U.S. Public Health Emergency 20.05.2026
Antiviral potential of galactose-binding lectin from Vatairea macrocarpa seeds against SARS-CoV-2 20.05.2026
Open Questions on Viral Frameshifting:Exploiting Structural Plasticity of the Frameshifting Element for Therapeutic Intervention. 19.05.2026
Exploring post-Covid-19 condition in children and young people 3.5 years after infection:a mixed-methods analysis from the CLoCk study. 19.05.2026
COVID-19 vaccination and antibody response in healthcare workers:a longitudinal serological study following the 2023-2024 COVID-19 vaccination campaign. 19.05.2026
Prevalence, associated factors and treatment prescriptions for community-acquired pneumonia:a cross-sectional study at the largest children's hospital in the Ashanti Region, Ghana. 19.05.2026
Machine learning framework for cost effective deep mutational scanning through targeted substitution profiling. 19.05.2026
TMPRSS2-induced Golgi disruption restricts the incorporation of virus envelope glycoproteins into virions. 19.05.2026
Metabolic impairments in peripheral blood mononuclear cells after BNT162b2 vaccination in liver transplantation adolescents. 19.05.2026
Population-based comparison of post-acute sequelae of COVID-19 and health-related quality of life across pandemic periods:Omicron era versus early pandemic. 19.05.2026
Dataset for selecting surrogates of emerging biothreat pathogens in laboratory research. 19.05.2026
Patient Characteristics and Healthcare Resource Use among Patients With COVID-19 Receiving Treatment with Nirmatrelvir/Ritonavir (PAXLOVID™) in the Kingdom of Saudi Arabia. 19.05.2026
C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms:Longitudinal Plasma Proteomics. 19.05.2026
Spatiotemporal distribution of SARS-CoV-2 vaccines and vaccine-related proteins in mice and humans. 19.05.2026
Shear strength of light weight concrete elements model based on deep neural network and COVID-19 optimization. 19.05.2026
Cross-resistance patterns in SARS-CoV-2 against 3CL protease inhibitors. 19.05.2026
Corrigendum to 'Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant' [Biomaterials, 128 (2021), 121159]. 19.05.2026
Measurement of quality of stroke care with national electronic health records:a prospective cohort study during and after the COVID-19 pandemic. 19.05.2026
From CRONOS to CRONOS-Kids:Investigating Neurological Development in Toddlers After Maternal SARS-CoV-2 Infection During Pregnancy - A Study Protocol For A Prospective Cohort Study. 19.05.2026
Human Papillomavirus Vaccine Discourse and Sentiment on Reddit Before and After COVID-19:Mixed Methods Retrospective Cross-Sectional Study. 19.05.2026
Antiviral potential of galactose-binding lectin from Vatairea macrocarpa seeds against SARS-CoV-2. 19.05.2026
COVID-19 Knowledge, Attitudes, and Practices and Perceived Risk:Cross-Sectional Mixed Methods Study. 19.05.2026
Safety of COVID-19 mRNA-1273 booster doses in Asian populations:A literature review of post-marketing observational studies. 19.05.2026
Shared autonomous HERV loci transcription identifies a unique circulating CD14+-xCR1+ mononuclear cell phenotype in a patient group with post-acute sequelae of COVID-19. 19.05.2026
Histopathological changes in the olfactory pathway in COVID-19:An autopsy-based case-control study. 19.05.2026
SARS-CoV-2 Vaccination Status and MIS-C Incidence:A Systematic Review 19.05.2026
Dual-Mode LSPR Biosensing of DNA and SARS-CoV-2 Spike Protein using Gold Nanorod-Coated Hetero-core Fiber 19.05.2026
Corrigendum to ‘Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant’ [Biomaterials, 128 (2021), 121159] 19.05.2026
Genomic Surveillance of Omicron SARS-CoV-2 Variants Circulating in Schools from Portugal and Italy in 2022 to 2024 19.05.2026
Wastewater Surveillance as an Event Detection System:Outbreak and Peak Detection of SARS-CoV-2 Across 281 U.S. Counties 19.05.2026
Infecção de explantes de tonsilas palatinas humanas com vírus respiratórios pandêmicos ; influenza e SARS-CoV-2 19.05.2026
Comparative Evaluation of SARS-CoV-2 RNA Concentration and Normalization Strategies in Prison Wastewater:Implications for Viral Dynamics in Confined Environments 19.05.2026
Association between living with children, vaccination, and outcomes from COVID-19:an OpenSAFELY cohort study of 12 million adults in England during 2021–22 19.05.2026
The Development of Aptamer-Functionalized Streptavidin Magnetic Particles for Sample Purification of SARS-CoV-2 Coupled with Rapid Plasmonic RT-qPCR to Improve Detection Sensitivity 19.05.2026
A funnel approach to enable analyses of epitope-specific human CD4 T cells specific for influenza and SARS-CoV-2 19.05.2026
Eficacia y seguridad del tratamiento con litio en pacientes infectados por SARS CoV- 2 19.05.2026
Pricktest und Basophilenaktivierungstest bei Überempfindlichkeitsreaktionen gegenüber SARS-CoV-2-Impfstoffen und deren Bestandteilen 19.05.2026
LAMP Combined with Nanopore Flongle Sequencing:A Rapid Point-of-Care Diagnostic for SARS-CoV-2 and Influenza B Virus Detection 19.05.2026
Circulating Extracellular Vesicles Drive Innate Immune Dysregulation in MIS-C. 18.05.2026
A phase I, needle free, dose escalation clinical trial of pEVAC-PS, a candidate pan-Sarbecovirus Vaccine. 18.05.2026
Dynamics and variant-specific patterns of SARS-CoV-2 reinfection in Ethiopia:a prospective longitudinal cohort study. 18.05.2026
Reproducible detection of antigen-specific T cells and Tregs via standardized and automated activation-induced marker assay workflows. 18.05.2026
Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution. 18.05.2026
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome:Successful Therapeutic Plasma Exchange Treatment After SARS-CoV-2 Infection-A Case Report. 17.05.2026
Drug-induced thrombocytopenia after SARS CoV-2 monoclonal antibody administration treated with plasma exchange. 15.05.2026
SARS-CoV-2 Reinfection and Risk of Multisystem Inflammatory Syndrome in Children:A Case-Control Study. 14.05.2026
Genetic variability of SARS-CoV-2 in wastewater and associations with community transmission. 14.05.2026
The Adjunctive Role of Hyperbaric Oxygen Therapy in Microbial Infection-Related Conditions. 11.05.2026
Effects of COVID-19 on parental perception of children's oral health-related quality of life. 08.05.2026
The Effect of Vaccination on the Evolution of the SARS-CoV-2 B.1.351 Variant 08.05.2026
SARS-CoV-2:To transgress or Not? 07.05.2026
Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19. 06.05.2026
Novel Competitive, Nonpeptidic, SARS-CoV‑2 M(pro) Inhibitors with Improved Solubility. 06.05.2026
De novo COVID-19-associated insulin resistance drives dysregulated neutrophil extracellular trap formation (NETosis) four months after infection. 04.05.2026
SARS-CoV-2 Infection and Rates of Neonatal Congenital Anomalies. 01.05.2026
SARS-CoV-2 Variants and Immune Evasion:Mapping the Future of Vaccine Design. 01.05.2026
SARS-CoV-2 in Pregnancy-More Hints of Rare Complications. 01.05.2026
Recent COVID-19 Vaccination and Risk of SARS-CoV-2 Transmission. 01.05.2026
Widespread SARS-CoV-2 Transmission Despite Limited Reported Cases and Clinical Disease:Exploring the Role of Pre-Existing Humoral Immunity to SARS-CoV-2 in Eastern Sierra Leone. 01.05.2026
Rapidly Enlarging Facial Mass Following SARS-CoV-2 Infection. 01.05.2026
Helminth infection is linked to an impaired neutralisation response to SARS-CoV-2 post vaccination 28.04.2026
Advances in molecular diagnostic strategies during the SARS-CoV-2 pandemic. 28.04.2026
Clustering of SARS-CoV-2 membrane proteins in lipid bilayer membranes. 27.04.2026
Association Between Post-COVID-19 Herpes Zoster Reactivation and Peripheral Nervous System Disorders:Multinational Real-World Evidence from TriNetX. 23.04.2026
Genomic and Phylogenetic Dissection of SARS-CoV-2 Transmission Networks in Healthcare Workers. 21.04.2026
Editorial:Exploring SARS-CoV-2 interactions in aging and comorbid populations 20.04.2026
Retrospective neutralization analysis of SARS-CoV-2 variants in early pandemic sera 20.04.2026
Advances in Ozone-Based Inactivation of SARS-CoV-2:An Updated Review. 18.04.2026
SARS-CoV-2 main protease inhibition by natural compounds. 17.04.2026
New transcription signals in SARS-CoV-2 reshape virus-host interactions. 17.04.2026
Diagnostic Performance Evaluation of the GXT96 X3 Extraction System with the FluoroType® SARS-CoV-2 varID Q Assay for Detection and Variant Identification of SARS-CoV-2 10.04.2026
SKIN AS A POTENTIAL ENTRY POINT FOR SARS-COV-2 08.04.2026
Investigation of mRNA expressions in nasopharyngeal and oropharyngeal swab samples in active SARS-CoV-2 infection and after SARS-CoV-2 infection. 26.03.2026
Quellen: PubMed, Europe PMC & CrossRef
Long Covid und ME/CFS: Heilung in drei Tagen? - WOZ Die Wochenzeitung 20.05.2026
Homepage | Reha-Angebot für COVID-19-Erkrankte - Deutsche Rentenversicherung 20.05.2026
Moderna Inc.-Aktie (US60770K1034): Impfstoff-Pionier setzt auf Blockbuster-Pipeline nach mRNA-Boom - AD HOC NEWS 20.05.2026
Wo bleibt das Sondervermögen für Long-Covid-Patienten? - Fränkischer Tag 20.05.2026
Homepage | Eckpunktepapier für die medizinische Rehabilitation bei Post-COVID-Syndrom - Deutsche Rentenversicherung 20.05.2026
Post-Covid nach Corona-Impfung? Arnsberger klagt gegen den Hersteller BioNTech - Westfalenpost 19.05.2026
Verliert LeAnn Rimes ihre Stimme nach COVID-19-Erkrankung endgültig? - BUNTE.de 19.05.2026
28 Minuten im TV Programm: 20.05. - 03:55 - Arte - HÖRZU 19.05.2026
ME/CFS-Konferenz Berlin: Rückschläge bei Therapiestudien - RiffReporter 17.05.2026
Long-Covid-Kolumne von Margarete Stokowski: Du siehst sportlich aus! - Apotheken Umschau 15.05.2026
Protesttag gegen Long Covid und CFS - tagesschau.de 09.05.2026
Falsche Zahlen zu angeblichen Impf-Toten - tagesschau.de 24.04.2026
Long-Covid-Kolumne von Margarete Stokowski: „Wie hältst du das aus?“ - Apotheken Umschau 15.04.2026
Myth-busters- debunking long COVID myths and misconceptions - World Health Organization (WHO) 31.03.2026
Langzeitfolgen nach Corona: Was Long-Covid-Betroffene in MV von der Politik erwarten - NDR.de 25.03.2026
Post-Covid-Expertin Scheibenbogen im Interview - NDR.de 25.03.2026
EVZ-Netz und COVID-19 - European Commission 16.03.2026
Rückblick auf die durch Long COVID verlorenen Jahre: Susans Geschichte - World Health Organization (WHO) 16.03.2026
Warken: „Wir wollen die Versorgung von Long-COVID-Betroffenen weiter verbessern“ - Bundesministerium für Gesundheit (BMG) 13.03.2026
Entlarvung von Mythen und falschen Vorstellungen über Long COVID - World Health Organization (WHO) 30.01.2026
Quelle: Google News
Pluslife ist ein Molekulartest (PoC-NAT) für zuhause: besser als Antigen-Schnelltests bei niedriger Viruslast – und mit Analyzer-Webapp von »virus.sucks« werden Ergebnisse nachvollziehbar.
Safe Air Docs hilft dabei, Arztpraxen mit hohen Infektionsschutzstandards zu finden. So wird der Arztbesuch sicherer – besonders für Menschen mit erhöhtem Gesundheitsrisiko.
Am 15. und 16. Mai 2024 fand die virtuelle Konferenz #UniteToFight2024 statt und zog über 10.000 Teilnehmer an, die sich über die neuesten Entwicklungen zu Long Covid und ME/CFS informierten. Führende Experten wie Dr. David Putrino und Prof. Akiko Iwasaki präsentierten aktuelle Forschungsergebnisse.
Die Übertragung durch Aerosole ist einer der am schwierigsten zu vermeidenden Infektionswege, kann aber durch FFP2- und FFP3-Masken effektiv blockiert werden.
2023: Golda Schlaff und 15 weitere prominente Ärzt:innen fordern mehr Respekt vor den Patient:innen, die Wiedereinführung von FFP2-Masken bei steigenden Inzidenzen sowie den flächendeckenden Einsatz von HEPA-Filtern in medizinischen Einrichtungen.